CREST-2 may end routine CEA for asymptomatic carotid stenosis, but its message is nuanced, raising new questions about patient selection, stenting, and when intervention still makes sense, experts say. Medscape Medical News
CREST-2 may end routine CEA for asymptomatic carotid stenosis, but its message is nuanced, raising new questions about patient selection, stenting, and when intervention still makes sense, experts say. Medscape Medical News